Across the tumor types, although we cannot perform a comparison between the different disease settings, the most overall ‘immuno-sensitive’ disease seems to be melanoma (as expected) where, even in the worst case (PD-L1 negative tumors) an activity of 26.2% is documented (Fig 4). Here, CD274 is linked to neoplasm.